I
ADMA icon

InceptionR’s ADMA Biologics ADMA Stock Holding History

InceptionR’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$181K Buy
21,634
+162
+0.8% +$1.48K 0.04% 599
2026
Q1 		$193K Buy
+21,472
New +$339K 0.05% 592
2025
Q2 		– Sell
-15,100
Closed -$300K – 635
2025
Q1 		$300K Sell
15,100
-11,278
-43% -$195K 0.09% 382
2024
Q4 		$452K Buy
+26,378
New +$496K 0.1% 357

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

InceptionR's ADMA Position: Q2 2026 in Review

InceptionR increased its ADMA Biologics (ADMA) stake by 0.75% in Q2 2026, buying an estimated $1.48K and bringing the position to 21,634 shares worth $181K. The position accounts for 0.04% of the portfolio, ranked #599.

InceptionR first reported a position in ADMA in Q4 2024 and has held it in 4 quarters since. The position peaked at $452K in Q4 2024. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • InceptionR held 21,634 shares of ADMA Biologics worth $181K as of Q2 2026.
  • InceptionR bought 162 ADMA Biologics shares in Q2 2026, an estimated $1.48K.
  • ADMA Biologics made up 0.04% of InceptionR's portfolio in Q2 2026, its #599 holding.
  • InceptionR first reported a position in ADMA Biologics in Q4 2024 and has held it in 4 quarters since.
  • InceptionR's ADMA Biologics position peaked at $452K in Q4 2024.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on InceptionR's 13F filing for Q2 2026, filed 11 Aug 2026.